Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at Texas Tech University Health Sciences Center (TTUHSC) and director of the ...
Sarcopenia as a marker to assess the surveillance necessity after a 5-year cancer-free period in patients who undergo radical cystectomy: A multi-institutional retrospective study.
TTUHSC’s Thomas E. Hutson, D.O., Pharm.D., Ph.D., shared groundbreaking findings from the landmark CLEAR study Feb. 13-14 at the 2025 American Society of Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback